Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
134studies shown
Showing 101-125 of 134
TerminatedNCT01121536

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Bipolarity
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherFrom 10 Years to 17 Years
Countries
Bulgaria, Colombia, France, Hungary, Mexico, Philippines, Poland, United States, South Korea, Ukraine
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT01072630

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, United States
Sponsor
Cephalon
Condition
Bipolarity
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Canada, Colombia, Czech Republic, France, India, Japan, Lithuania, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa, Ukraine, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
TerminatedNCT01809340

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

This study exists to compare options and see whether ketamine treatment offers something meaningfully different. Researchers are trying to understand whether ketamine treatment can better prevent setbacks and support longer-term stability.

DepressionOtherFrom 18 Years to 80 Years
Countries
Belgium, France, Netherlands, Spain
Sponsor
Janssen Research & Development, LLC
Condition
Depression
CompletedNCT00868452

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

This study exists to explore whether the medication Patients could improve care and understanding. Researchers are trying to understand what the medication Patients could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Czech Republic, France, Germany, India, Poland, Romania, Russian Federation, South Africa, Ukraine, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT00868699

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Czech Republic, France, India, Romania, Russian Federation, South Africa, Ukraine, United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
CompletedNCT02542891

European Comparative Effectiveness Research on Internet-based Depression Treatment

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Depression
Not Yet RecruitingNCT07545928

Single Arm, Monocentric, Pilot Feasibility Study on an Interactive Virtual Reality Program in 20 Complex In-clinic Palliative Care Patients

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

AnxietyOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Anxiety
Not Yet RecruitingNCT07539207

Precarity and Reduction of Its Impact on the Mental Health of Health Students

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

DepressionOtherFrom 18 Years to 30 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Depression
CompletedNCT06133309

Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Condition
Depression
CompletedNCT04903522

Can the Affects Conveyed by Baroque Music Reduce Anxiety in Patients With Major Depressive Disorder ?

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Condition
Depression
CompletedNCT01466439

Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Schizophrenia
CompletedNCT03424486

Prevalence and Impact of Depression and Anxiety in Cystic Fibrosis

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

AnxietyOtherFrom 14 Years to 17 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Anxiety
TerminatedNCT06635135

A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure

This study exists to understand what helps the medication Aticaprant work in everyday practice, not just under ideal conditions. Researchers are trying to understand what the medication Aticaprant could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 64 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, France, Germany, Greece, Mexico, Poland, Romania, Spain, Turkey, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
WithdrawnNCT03060967

Assessment of Hedonic and Motivational States in Major Depression ( MOODDIS)

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Depression
CompletedNCT03565562

Preventing Psychological Distress and Suicidal Behaviours: a Web-based and Mobile Suicide Prevention Intervention in the General Population

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what helps a digital app or remote support tool stay useful, realistic, and easier to follow over time.

AnxietyOtherOver 18 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Anxiety
CompletedNCT05550532

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

This study exists to understand what helps the medication Aticaprant work in everyday practice, not just under ideal conditions. Researchers are trying to understand how people respond to the medication Aticaprant in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Bulgaria, Canada, China, Czech Republic, France, Poland, Slovakia, South Africa, South Korea, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
TerminatedNCT04456868

Neurophysiological Markers in the Depressive Episode Characterized by Anhedonic Drug Resistance: Evaluation of Motor Skills and P300 Wave

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
University Hospital, Rouen
Condition
Depression
CompletedNCT01903655

Study of the Telomere-telomerase System and the Expression of Candidate Genes in the Leukocytes of Patients With Depressive Disorder: Search for Peripheral Markers of Somatic Stress

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

DepressionOther
Countries
France
Sponsor
Centre Hospitalier Universitaire Dijon
Condition
Depression
CompletedNCT07380074

Mental Health Outcomes and Variations in Exercise in Residents

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

AnxietyOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Anxiety
CompletedNCT04362358

Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Depression
Depression | Clinical Trials | HopeStage Research